Abstract PS9-02: Neratinib + capecitabine sustains health-related quality of life (HRQoL) while improving progression-free survival (PFS) in patients with HER2+ metastatic breast cancer and ≥2 prior HER2-directed regimens

Beverly Moy,Mafalda Oliveira,Cristina Saura,William Gradishar,Sung-Bae Kim,Adam Brufsky,Sara Hurvitz,Larisa Ryvo,Daniele Fagnani,Nancy Chan,Sujith R Kalmadi,Paula Silverman,Suzette Delaloge,Richard Bryce,Kiana Keyvanjah,Judith Bebchuk,Bo Zhang,Nina Oestreicher,Ron Bose

user-5f8411ab4c775e9685ff56d3（2021）

引用 1|浏览6

暂无评分

关键词

Neratinib,Capecitabine,Metastatic breast cancer,Progression-free survival,Oncology,Medicine,Health related quality of life,In patient,Internal medicine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要